Apimeds Pharmaceuticals US, Inc. (APUS) vs Gelteq Limited (GELS)

Apimeds Pharmaceuticals US, Inc. and Gelteq Limited are both Drug Manufacturers Specialty & Generic companies. Apimeds Pharmaceuticals US, Inc. is the larger, with a market value of $7.6M against $5.9M — 1.3× the size. Across the 8 metrics below, Gelteq Limited leads on 6 and Apimeds Pharmaceuticals US, Inc. on 2.

Valuation

Metric APUS GELS Drug Manufacturers Specialty & Generic median
P/E n/m — 20.14
P/S n/m — 2.25
P/B 0.12 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m n/m 2.56
Earnings yield (504.41%) — (2.99%)
Free cash flow yield (107.35%) 0.00% 0.00%

Profitability

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Gross margin — — 53.94%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (100.13%) 0.00% (0.40%)
Return on assets (84.20%) 0.00% (3.32%)
Return on invested capital (15.96%) 0.00% 0.00%

Growth

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) (205.56%) (62.07%) —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Debt to equity 0.08 0.36 0.05
Current ratio 0.51 0.09 2.31
Net debt to EBITDA 0.38 (0.91) 0.85

Dividend

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — — 0.00

Size

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Market cap 7.59m 5.89m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack